27.13
price down icon8.59%   -2.56
 
loading
Instil Bio Inc stock is traded at $27.13, with a volume of 80,242. It is down -8.59% in the last 24 hours and up +18.15% over the past month. Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$29.69
Open:
$29.77
24h Volume:
80,242
Relative Volume:
0.25
Market Cap:
$177.94M
Revenue:
-
Net Income/Loss:
$-74.14M
P/E Ratio:
-2.3819
EPS:
-11.39
Net Cash Flow:
$-65.70M
1W Performance:
-4.57%
1M Performance:
+18.15%
6M Performance:
+3.15%
1Y Performance:
+123.03%
1-Day Range:
Value
$27.13
$29.77
1-Week Range:
Value
$27.13
$32.76
52-Week Range:
Value
$9.85
$92.00

Instil Bio Inc Stock (TIL) Company Profile

Name
Name
Instil Bio Inc
Name
Phone
(972) 499-3350
Name
Address
3963 MAPLE AVENUE, DALLAS
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
TIL's Discussions on Twitter

Compare TIL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TIL
Instil Bio Inc
27.13 207.88M 0 -74.14M -65.70M -11.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
467.96 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.35 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.89 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
593.35 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
303.67 31.54B 3.81B -644.79M -669.77M -6.24

Instil Bio Inc Stock (TIL) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-07-25 Upgrade Jefferies Hold → Buy
Nov-04-24 Initiated JMP Securities Mkt Perform
Apr-12-24 Downgrade Jefferies Buy → Hold
Nov-01-22 Downgrade Cowen Outperform → Market Perform
Nov-01-22 Downgrade Truist Buy → Hold
Aug-13-21 Initiated Robert W. Baird Outperform
Apr-13-21 Initiated Cowen Outperform
Apr-13-21 Initiated Morgan Stanley Equal-Weight
Apr-13-21 Initiated Truist Buy
View All

Instil Bio Inc Stock (TIL) Latest News

pulisher
08:04 AM

How to interpret RSI for Instil Bio Inc. stockStable Profit Zone and Loss Control Analysis - Newser

08:04 AM
pulisher
05:51 AM

What high frequency data says about Instil Bio Inc.Trading Volume Anomaly Summary and Insight - Newser

05:51 AM
pulisher
04:21 AM

What makes Instil Bio Inc. stock price move sharplyStrong Buy Signal Summary with Entry Zone - Newser

04:21 AM
pulisher
12:17 PM

Will Instil Bio Inc. stock benefit from interest rate changesStrong Buy Opportunity with Volume Support - Newser

12:17 PM
pulisher
Jul 28, 2025

How volatile is Instil Bio Inc. stock compared to the marketDouble-digit growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How to interpret RSI for Instil Bio Inc. stock High Return Idea With Technical Filter - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Candlestick signals on Instil Bio Inc. stock today Free Wealth Building Stock Market Ideas - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What are Instil Bio Inc. company’s key revenue driversUnlock daily market insights for better trades - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Instil Bio Inc. compare to its industry peersAchieve rapid financial growth with expert help - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in Instil Bio Inc. stockHigh-margin investment plays - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Instil Bio Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWatchlist Winner Update - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Is Instil Bio Inc. stock overvalued or undervaluedFree Stock Movement Tracking - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Instil Bio Inc. company’s balance sheetUnlock daily market insights for better decisions - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Should I hold or sell Instil Bio Inc. stock in 2025Get timely market insights for better trades - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Instil Bio Inc. Stock Support and Resistance Levels You Should KnowFree Market Sentiment Analysis - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Is Instil Bio Inc. a good long term investmentUnrivaled growth potential - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Should I buy Instil Bio Inc. stock before earningsBreakthrough financial growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Will Instil Bio Inc. stock benefit from AI tech trendsAccelerated capital growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Instil Bio Inc. stockFree Investment Community - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Instil Bio Inc. Stock Analysis and ForecastOver 200% growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Can Instil Bio Inc. stock recover from recent declineRecord-breaking capital gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 22, 2025

What drives Instil Bio Inc. stock priceExceptional portfolio growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

(TIL) Proactive Strategies - news.stocktradersdaily.com

Jul 20, 2025

Instil Bio Inc Stock (TIL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$76.00
price up icon 8.22%
$37.33
price up icon 0.73%
$103.19
price up icon 1.42%
$26.62
price down icon 3.28%
$109.69
price down icon 2.74%
biotechnology ONC
$303.07
price up icon 2.85%
Cap:     |  Volume (24h):